Effects of prostaglandins and leukotrienes on hypoxic pulmonary vasoconstriction in rats.
To investigate the effects of prostaglandins (PGs) and leukotrienes (LTs) on hypoxic pulmonary vasoconstriction (HPV), in vivo rats experiment and in vitro perfused lung experiment were conducted. The effect of hypoxia on hemodynamics, concentrations of TXB2 and 6-keto-PGF1 alpha in serum and lung tissue during hypoxia and effects of PGs and LTs on HPV were observed. The results showed that pulmonary arterial pressure (Ppa) and pulmonary vascular resistance were increased during hypoxia, but cardiac output and systemic arterial pressure were decreased. There were increases of the concentrations of TXB2 and 6-keto-PGF1 alpha and their ratio in serum and lung tissue during hypoxia. After use of cyclooxygenase inhibitor (indomethacin) in vivo and in vitro, HPV was augmented respectively, but after use of lipoxygenase inhibitor (diethylcorbamazine) or leukotriene receptor blocker (LY-171883), HPV was attenuated. It was suggested that LTs mediated pulmonary vasoconstriction, PGs inhibited pulmonary vasoconstriction and they played a modulating role during hypoxia.
Yang
G
G
Department of Emergency, Tongji Hospital, Tongji Medical University, Wuhan 430030.
Chen
G
G
Wang
D
D
D015121:6-Ketoprostaglandin F1 alpha / Q000378:metabolism; D000818:Animals; D006439:Hemodynamics; D000860:Hypoxia / Q000503:physiopathology*; D015289:Leukotrienes / Q000502:physiology*; D011453:Prostaglandins / Q000502:physiology*; D011651:Pulmonary Artery / Q000503:physiopathology*; D051381:Rats; D017208:Rats, Wistar; D013929:Thromboxane B2 / Q000378:metabolism; D014661:Vasoconstriction
D015289:Leukotrienes; D011453:Prostaglandins; D013929:Thromboxane B2; D015121:6-Ketoprostaglandin F1 alpha